BM-MSCs are primed in vivo in a heart with myocardial infarction by genetically engineered MSCs expressing hepatocyte growth factor (HGF-eMSC) that are encapsulated within an epicardially implanted cardiac 3D patch. The gene discussed is HGF; the disease is myocardial infarction.